1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Ketone body concentrations as measured by MR spectroscopy before and after treatment with a ketogenic diet in both the lesion and contralateral braina
Baseline (IU) No. Week 8 (IU) No. P Value Ace Contralateral brain 0.04 ± 0.01 5 0.16 ± 0.04 9 .004b Lesion 0.06 ± 0.03 4 0.27 ± 0.06 9 .005b bHB Contralateral brain 0.09 ± 0.06 2 0.28 ± 0.08 6 .12 Lesion 0.07 ± 0.07 1 0.79 ± 0.32 5 .046c AcAc Contralateral brain 0.07 ± 0.04 3 0.06 ± 0.03 3 .76 Lesion 0.03 ± 0.03 1 0.02 ± 0.02 1 .72